Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes

Endocrinol Metab Clin North Am. 2007 Dec:36 Suppl 2 Incretin:2-17.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use
  • Glycoside Hydrolase Inhibitors
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Incretins / analogs & derivatives
  • Incretins / physiology*
  • Incretins / therapeutic use*
  • Insulin / therapeutic use
  • Insulin Resistance / physiology
  • Metformin / therapeutic use
  • Sulfonylurea Compounds / therapeutic use
  • Thiazolidinediones / therapeutic use
  • Treatment Outcome
  • alpha-Glucosidases / therapeutic use

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Glycoside Hydrolase Inhibitors
  • Hypoglycemic Agents
  • Incretins
  • Insulin
  • Sulfonylurea Compounds
  • Thiazolidinediones
  • Metformin
  • alpha-Glucosidases